PhD Simon Žakelj
no.: 22659

researcher – active in research organisation

01 47 69 500
simon.zakelj at sign

at sign

ffa.uni-lj.si

Research activity

Code	Science	Field	Subfield
1.09.00	Natural sciences and mathematics	Pharmacy

Keywords

Permeability, absortption through rat jejunum, Sweetana-Grass diffusion cells, artificial membranes

Bibliography Representative bibliographic units | Personal| COBISS+

source: COBISS

source: SICRIS

Evaluation (rules)

Evaluation of bibliographic research performance indicators according to ARIS methodology

source: COBISS

source: ARIS

Points

360.75

A''

13.96

A'

194.58

A1/2

194.58

CI10

761

CImax

106

h10

15

A1

1.23

A3

1

Data for the last 5 years (citations for the last 10 years) on April 25, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)

Data for ARIS tenders ( 12.01.2024 – Project tender, archive )

Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases

source: WoS

source: Scopus

source: COBISS

Database	Linked records	Citations	Pure citations	Average pure citations
WoS	43	887	758	17.63
Scopus	42	970	838	19.95

Education

source: ARIS

Level of education	Professional title	Study subject	Faculty	Year
	B. Sc.	Pharmacy	University of Ljubljana, Faculty of Pharmacy	2001
Doctor's degree	Ph. D.		University of Ljubljana, Faculty of Pharmacy	2006

Doctoral dissertations and other final papers Show

source: COBISS

Employments

source: ARIS

Type of employment	Research org.	Research group	Date of employment	Position	ecris.org.employ_rolegroup	Title
Full time employment (120%, RD:20%)	University of Ljubljana, Faculty of Pharmacy	Chair of Pharmaceutical Technology	1/1/2002	Assistant	Researcher	Associate professor

Research projects Legend

source: ARIS

no.	Code	Title	Period	Head	No. of publications
1.	J1-50023	3DfluorCO - Three-dimensional fluorine-based carbonyl bioisosteres: asymmetric synthesis and validation	2023 - 2024	PhD Andrej Emanuel Cotman	1,045
2.	J1-50037	Development of CDK1-selective degraders for the treatment of T-cell malignancies	2023 - 2024	PhD Izidor Sosič	1,093
3.	J4-50139	Valorization of Himalayan balsam (Impatiens glandulifera Royle) waste to design bioactive extracts with a potential protective activity on the human vascular system	2023 - 2024	PhD Alen Albreht	1,340
4.	J7-4635	MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy	2022 - 2024	PhD Lucija Peterlin Mašič	6,051
5.	L1-3160	Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration	2021 - 2024	PhD Iztok Grabnar	2,929
6.	J1-2484	Development of antibacterial compounds targeting validated enzymes in peptidoglycan biosynthesis	2020 - 2023	PhD Stanislav Gobec	3,864
7.	L2-7550	Elecrospun nanofibrous materials for solid state drug delivery system	2016 - 2019	PhD Igor Emri	4,425
8.	J3-4313	The influence of active transport and patients' genotypes on the therapeutic outcome of chronic myeloic leukemia	2011 - 2014	PhD Albin Kristl	3,122
9.	J1-0957	Pharmacogenetic study of raloxifene metabolism and transport	2008 - 2011	PhD Aleš Mrhar	1,948

ARIS research and infrastructure programmes Legend

source: ARIS

no.	Code	Title	Period	Head	No. of publications
1.	P1-0189	Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children end elderly	2018 - 2024	PhD Mitja Kos	6,875
2.	P1-0189	Pharmaceutical technology: from drug delivery systems to therapeutic outcomes of medicines in children end elderly	2014 - 2017	PhD Albin Kristl	6,866
3.	P1-0189	Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih (Slovene)	2009 - 2013	PhD Aleš Mrhar	6,978
4.	P1-0189	Pharmaceutical technology: design, preparation and evaluation of drug delivery systems	2004 - 2008	PhD Aleš Mrhar	6,980